BAP1 and cholangiocarcinoma: In addition, CCA cluster 3/4 are characterized by high copy number alterations and expression of PD-1/PD-L2 or epigenetic changes (IDH1/2, BAP1) along with FGFR/PRKA-related gene rearrangements.